Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

General purpose FDA user fees

This article was originally published in The Tan Sheet

Executive Summary

Pharmaceutical Research & Manufacturers of America urges Senate Appropriations/agriculture subcommittee conferees in Aug. 4 letter to eliminate $163.4 mil. in general purpose user fees included in the final version of the Senate's FY 1995 agriculture appropriations bill (HR 4554) adopted on July 20. Last year, House-Senate conferees deleted $175 mil. in unspecified user fees from the FY 1994 spending bill approved by the Senate. A conference date for the FY 1995 legislation has not yet been set
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel